PERRIGO COMPANY PLC |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30.66 USD | -0.18% |
|
-8.29% | -4.72% |
| 05-07 | Perrigo's Q1 Adjusted Earnings, Net Sales Drop | MT |
| 05-07 | Transcript : Perrigo Company plc, Q1 2024 Earnings Call, May 07, 2024 |
Presenter SpeechBradley Joseph (Executives)Good morning, everybody. Thank you for coming here,...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Perrigo Company plc is an Ireland-based provider of over the counter (OTC) health and wellness solutions that are designed to enhance individual well-being. The Company's segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises its consumer self-care business (OTC, infant formula, and oral care categories, and contract manufacturing) in the United States and Canada, including the HRA Pharma self-care business (Women's Health and Skin-Care categories) in the United States and Canada. The CSCI segment comprises its consumer self-care business in Europe and Australia, which are primarily branded, its store brand business in the United Kingdom and parts of Europe and Asia and includes the HRA Pharma self-care business (Women's Health, Skin-Care and Rare-Disease categories) in Europe. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, Nutrition and others.
Sector
Pharmaceuticals
Calendar
2024-05-30
- Ex-dividend day
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
30.71
USD
Average target price
39.5
USD
Spread / Average Target
+28.62%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -4.72% | 4.19B | |
| +29.55% | 684B | |
| +30.34% | 568B | |
| -4.03% | 361B | |
| +17.91% | 329B | |
| +3.95% | 284B | |
| +16.21% | 240B | |
| +9.66% | 208B | |
| -6.83% | 200B | |
| +6.91% | 166B |
- Stock Market
- Equities
- PRGO Stock
- News Perrigo Company plc
- Transcript : Perrigo Company plc - Analyst/Investor Day
